SFM
PTX

Sphera Funds Management’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Sphera Funds Management’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-5,650
Closed -$142K – 147
2013
Q4 		$142K Buy
+5,650
New +$135K 0.04% 96

Other funds holding PTX

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SC
Sageview Capital Greenwich, Connecticut $177M AUM 36.56% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FCAM
F&C Asset Management Edinburgh, Scotland, United Kingdom $7.92B AUM 24.35% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
EWP
Edmunds White Partners Richmond, Virginia $69.2M AUM 56.3% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sphera Funds Management's PTX Position: Q1 2014 in Review

Sphera Funds Management sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2014, closing a stake of 5,650 shares — an estimated $142K sold.

Sphera Funds Management first reported a position in PTX in Q4 2013 and held it in 1 quarter. The position peaked at $142K in Q4 2013. 63 funds tracked by Wall St. Rank hold PTX as of Q1 2014.

  • Sphera Funds Management reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2014 after selling out during the quarter.
  • Sphera Funds Management sold 5,650 Pernix Therapeutics Holdings, Inc. shares in Q1 2014, an estimated $142K.
  • Sphera Funds Management first reported a position in Pernix Therapeutics Holdings, Inc. in Q4 2013 and held it in 1 quarter.
  • Sphera Funds Management's Pernix Therapeutics Holdings, Inc. position peaked at $142K in Q4 2013.
  • 63 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2014.

Based on Sphera Funds Management's 13F filing for Q1 2014, filed 14 May 2014.